Email updates

Keep up to date with the latest news and content from Malaria Journal and BioMed Central.

This article is part of the supplement: Parasite to Prevention: Advances in the understanding of malaria

Open Access Poster presentations

The genetic change in P. falciparum populations of rural Tanzania resulting from national policy on firstline malaria treatment and pilot Sulfadoxine/pyrimethamine and Artesunate combination

Allen Malisa12*, Richard Pearce3, Salim Abdullah1, Hassan Mshinda1, Patrick Kachur4, Peter Bloland4 and Cally Roper3

  • * Corresponding author: Allen Malisa

Author Affiliations

1 Ifakara Health Institute, Box 53, Ifakara, Tanzania

2 Sokoine University of Agriculture, Department of Biological Sciences, PO Box 3038, Morgoro, Tanzania

3 London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E7HT, UK

4 Malaria Epidemiology Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA

For all author emails, please log on.

Malaria Journal 2010, 9(Suppl 2):P20  doi:10.1186/1475-2875-9-S2-P20

The electronic version of this article is the complete one and can be found online at: http://www.malariajournal.com/content/9/S2/P20


Published:20 October 2010

© 2010 Malisa et al; licensee BioMed Central Ltd.

This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Poster presentations

Theory predicts that we can protect the efficacy of future antimalarials by changing treatment practice or drug formulation, but the potential success of such interventions rests upon their impact on drug pressure in the field. So far, gathering field data on the relationship between policy, drug pressure, recombination and the evolution of resistance has been entirely challenging. To test these predictions, dhfr and dhps frequency changes were measured in two rural districts of Rufiji and Kilombero/Ulanga during 2000-2006, and the frequencies of the two genes compared prior, during and after antimalarial policy change from first line CQ to first line SP in 2001. Furthermore, while SP first line was maintained in Kilombero/Ulanga, pilot combination therapy of SP+Artesunate (ART) was introduced in Rufiji in 2002 to replace SP and dhfr and dhps frequency changes compared between the two districts. Size polymorphisms at three sets of microsatellite loci linked to dhfr and three other sets of unlinked microsatellite loci were analysed. Genetic analysis of SP resistance genes was carried out on 9,662 Plasmodium falciparum infections identified in a series of annual cross sectional surveys conducted in the two districts between 2000-2006.

The frequency of dhfr and dhps resistance alleles did not change significantly while SP was the recommended second-line treatment, but highly significant changes occurred during the subsequent year after the switch to first line SP. The frequency of the triple mutant dhfr allele increased by 37% -63% and that of double mutant dhps allele increased 200%-300%. A strong association between these unlinked alleles also emerged; confirming that they are co-selected by SP. Distribution of major lineages indicates that there is extensive genetic exchange among the geographic regions. Combination therapy had visible effect on the frequencies of dhfr and dhps resistance alleles. The findings of this study provide insight on the interplay between policy, drug pressure, recombination and the evolution of resistance.